News
August 02, 2012
Guttridge to assume new position in the department of Molecular Virology, Immunology and Medical Genetics.
The rest of the story
|
|
July 19, 2012
Carlo Croce, MD, director of Human Cancer Genetics and the John W. Wolfe Chair in Human Cancer Genetics at the Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, talks about three areas of progress in cancer research since passage of the National Cancer Act in 1971: Why cancer still is not cured, significant areas of progress in cancer research since 1971, and how we should evaluate progress in cancer research.
The rest of the story
|
|
July 19, 2012
Internationally recognized cancer researcher and physician stregthens Trovagene's scientific expertise in cancer genetics
The rest of the story
|
|
July 17, 2012
Carlo Croce, MD, Chair,Department of Molecular Virology, Immunology, and Medical Genetics,Director, Institute of Genetics, John W. Wolfe Chair in Human Cancer, Genetics, Director, Human Cancer Genetics Program, received the 2012 Distinguished University Professor Award by The Ohio State University Office of Academic Affairs and the Board of Trustees.
The rest of the story
|
|
May 12, 2011
COLUMBUS, Ohio – Researchers have identified characteristic patterns of molecules called microRNA (<a href="http://en.wikipedia.org/wiki/MicroRNA" target="_blank">miRNA</a>) in the blood of people with ...
The rest of the story
|
|
April 18, 2011
COLUMBUS, Ohio – A new study shows how inflammation can help cause cancer. Chronic inflammation due to infection or to conditions such as chronic inflammatory bowel disease is associated with up to 25 ...
The rest of the story
|
|
March 24, 2011
COLUMBUS, Ohio – The human immunodeficiency virus (<a href="http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/Pages/whatAreHIVAIDS.aspx" target="_blank">HIV</a>), the cause of AIDS, makes use of the ...
The rest of the story
|
|
January 25, 2011
COLUMBUS, Ohio – A study shows for the first time that the three most common chromosome changes seen in chronic lymphocytic leukemia disrupt a molecular network that includes several important genes and ...
The rest of the story
|
|
January 13, 2011
COLUMBUS, Ohio – A new study by Ohio State University cancer researchers provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing ...
The rest of the story
|
|
October 26, 2010
COLUMBUS, Ohio – New research links three molecules to a critical tumor suppressor gene that is often turned off in multiple myeloma, a presently incurable cancer of the blood.
The findings might offer ...
The rest of the story
|
|
Next
|
